The epidemiology of psoriatic arthritis: A literature review
- PMID: 34016528
- DOI: 10.1016/j.berh.2021.101692
The epidemiology of psoriatic arthritis: A literature review
Abstract
Psoriatic arthritis (PsA) is a chronic, progressive musculoskeletal disease that affects 0.1%-1% of the general population and ~20% of patients with psoriasis. Significant differences exist in epidemiological estimates between studies, likely related to methodological and geographic differences. While most studies show an increase in prevalence over recent years, the underdiagnosis of PsA persists. Studies suggest that a complex interaction of multiple factors is involved in the development of PsA in patients with psoriasis and a single factor may not be able to effectively define at-risk patients with PsA. Modification of some risk factors such as weight loss may help in the prevention of the disease and improved outcomes.
Keywords: Comorbidity; Epidemiology; Mortality; Psoriatic arthritis; Risk factors; Spondyloarthritis.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest Dr. Ogdie has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB (less than 10,000 each) and has received grants from Novartis and Pfizer to Penn and from Amgen to Forward (grants more than 10,000).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
